🔎 Trials Near Me

Akèy › Kansè nan tete › Connecticut › Hartford

Etid klinik pou Kansè nan tete nan Hartford, CT

9 etid pou Kansè nan tete ap chèche patisipan nan sit nan ak bò kote Hartford (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study

Ap rekriteFaz 3
  • Smilow Cancer Hospital at Saint Francis, Hartford
  • Smilow Cancer Hospital at Glastonbury, Glastonbury · 5 mi lwen
Laj 60 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT06377852

Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer

Ap rekrite
  • Hartford Healthcare Institute, Hartford
Laj 18 ak plis · Tout sèks · Mizajou Sep 23, 2026 · NCT07214532

Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

Ap rekriteFaz 3
  • Hartford Hospital, Hartford
  • Smilow Cancer Hospital Care Center at Saint Francis, Hartford
  • Smilow Cancer Hospital Care Center at Glastonbury, Glastonbury · 5 mi lwen
  • ak 3 plis
Laj 18 a 60 · Fanm · Mizajou Sep 2, 2026 · NCT05879926

ATEMPT 2.0: Adjuvant T-DM1 vs TH

Ap rekriteFaz 2
  • Smilow Cancer Hospital Care center at St. Francis, Hartford
  • Smilow Cancer Hospital Care center at Glastonbury, Glastonbury · 5 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Aug 19, 2026 · NCT04893109

Integrated Cancer Repository for Cancer Research

Ap rekriteEtid obsèvasyonVolontè an sante akeyi
  • Hartford HealthCare Cancer Institute at Manchester Medical Hospital, Manchester · 8 mi lwen
Laj 19 a 110 · Tout sèks · Mizajou Jun 29, 2026 · NCT02012699

A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.

Ap rekriteFaz 3
  • Smilow Cancer Hospital at Saint Francis, Hartford
  • Smilow Cancer Hospital - Glastonbury, Glastonbury · 5 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou May 6, 2026 · NCT07062965

De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)

Ap rekriteFaz 3
  • Smilow Cancer Hospital Care Center at Saint Francis, Hartford
  • Smilow Cancer Hospital Care Center at Glastonbury, Glastonbury · 5 mi lwen
Laj 50 a 70 · Tout sèks · Mizajou Apr 23, 2026 · NCT04852887

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Ap rekriteEtid obsèvasyon
  • Massive Bio SYNERGY-AI site, Hartford
Tout laj · Tout sèks · Mizajou Oct 28, 2025 · NCT03452774

Etid Kansè nan tete nan lòt vil

Lòt etid nan Hartford

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.